Betta Pharmaceuticals Co Ltd
SZSE:300558
Betta Pharmaceuticals Co Ltd
Operating Income
Betta Pharmaceuticals Co Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
B
|
Betta Pharmaceuticals Co Ltd
SZSE:300558
|
Operating Income
¥421.7m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Operating Income
¥2.6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Operating Income
¥3.5B
|
CAGR 3-Years
21%
|
CAGR 5-Years
22%
|
CAGR 10-Years
22%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Operating Income
¥4.8B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
1%
|
CAGR 10-Years
12%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Operating Income
¥3.9B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
4%
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Operating Income
-¥749.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Betta Pharmaceuticals Co Ltd's Operating Income?
Operating Income
421.7m
CNY
Based on the financial report for Mar 31, 2024, Betta Pharmaceuticals Co Ltd's Operating Income amounts to 421.7m CNY.
What is Betta Pharmaceuticals Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
15%
Over the last year, the Operating Income growth was 233%. The average annual Operating Income growth rates for Betta Pharmaceuticals Co Ltd have been -1% over the past three years , 15% over the past five years .